Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
Effects of a low salt diet on isolated systolic hypertension: a communitybased population study
There is no simple yes or no
If a vendor cannot produce a CoA for each batch, do not buy from them
skin regeneration Boosts production of type I and III collagen, key proteins for skin structure, by up to 70% in human skin cells
Knocked down by no validated PHQ, no dedicated eating-disorder screen, no substance/alcohol screen, and a free-text-free meds review